{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:19:49Z","timestamp":1761513589504},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T00:00:00Z","timestamp":1423785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00430-015-0390-5","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T10:27:26Z","timestamp":1423736846000},"page":"613-618","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics"],"prefix":"10.1007","volume":"204","author":[{"given":"Jens","family":"Verheyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kseniya","family":"Maizus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zebulon","family":"Tolman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Knops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasemine","family":"Saech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd R.","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pawlita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Rubbert-Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"issue":"7","key":"390_CR1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","volume":"301","author":"A Strangfeld","year":"2009","unstructured":"Strangfeld A, Listing J, Herzer P, Liebhaber A, Rockwitz K, Richter C, Zink A (2009) Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. JAMA 301(7):737\u2013744. doi: 10.1001\/jama.2009.146","journal-title":"JAMA"},{"issue":"8","key":"390_CR2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","volume":"10","author":"L Kappos","year":"2011","unstructured":"Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdova E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O\u2019Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Radu EW, Sorensen PS, King J (2011) Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol 10(8):745\u2013758. doi: 10.1016\/S1474-4422(11)70149-1","journal-title":"Lancet Neurol"},{"issue":"9","key":"390_CR3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","volume":"68","author":"DB Clifford","year":"2011","unstructured":"Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL (2011) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68(9):1156\u20131164. doi: 10.1001\/archneurol.2011.103","journal-title":"Arch Neurol"},{"issue":"12","key":"390_CR4","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1002\/art.24966","volume":"60","author":"ES Molloy","year":"2009","unstructured":"Molloy ES, Calabrese LH (2009) Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 60(12):3761\u20133765. doi: 10.1002\/art.24966","journal-title":"Arthritis Rheum"},{"key":"390_CR5","author":"ES Molloy","year":"2012","unstructured":"Molloy ES, Calabrese LH (2012) Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum. doi: 10.1002\/art.34468","journal-title":"Arthritis Rheum"},{"issue":"Pt 7","key":"390_CR6","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1099\/vir.0.020115-0","volume":"91","author":"A Antonsson","year":"2010","unstructured":"Antonsson A, Green AC, Mallitt KA, O\u2019Rourke PK, Pawlita M, Waterboer T, Neale RE (2010) Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians. J Gen Virol 91(Pt 7):1849\u20131853. doi: 10.1099\/vir.0.020115-0","journal-title":"J Gen Virol"},{"issue":"6","key":"390_CR7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1086\/597126","volume":"199","author":"A Egli","year":"2009","unstructured":"Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199(6):837\u2013846","journal-title":"J Infect Dis"},{"issue":"12","key":"390_CR8","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/jnnp.2009.201079","volume":"81","author":"L Rinaldi","year":"2010","unstructured":"Rinaldi L, Rinaldi F, Perini P, Calabrese M, Seppi D, Grossi P, Mattisi I, Barzon L, Mengoli C, Sanzari M, Palu G, Gallo P (2010) No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18\u00a0month follow-up study. J Neurol Neurosurg Psychiatr 81(12):1345\u20131350. doi: 10.1136\/jnnp.2009.201079","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"3","key":"390_CR9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.22107","volume":"68","author":"RA Rudick","year":"2010","unstructured":"Rudick RA, O\u2019Connor PW, Polman CH, Goodman AD, Ray SS, Griffith NM, Jurgensen SA, Gorelik L, Forrestal F, Sandrock AW, EG S (2010) Assessment of JC virus DNA in blood and urine from natalizumab-treated patients. Ann Neurol 68(3):304\u2013310. doi: 10.1002\/ana.22107","journal-title":"Ann Neurol"},{"issue":"1","key":"390_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/infdis\/jir198","volume":"204","author":"L Gorelik","year":"2011","unstructured":"Gorelik L, Reid C, Testa M, Brickelmaier M, Bossolasco S, Pazzi A, Bestetti A, Carmillo P, Wilson E, McAuliffe M, Tonkin C, Carulli JP, Lugovskoy A, Lazzarin A, Sunyaev S, Simon K, Cinque P (2011) Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. J Infect Dis 204(1):103\u2013114. doi: 10.1093\/infdis\/jir198","journal-title":"J Infect Dis"},{"issue":"20","key":"390_CR11","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1128\/JVI.00614-10","volume":"84","author":"R Gosert","year":"2010","unstructured":"Gosert R, Kardas P, Major EO, Hirsch HH (2010) Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate. J Virol 84(20):10448\u201310456. doi: 10.1128\/JVI.00614-10","journal-title":"J Virol"},{"issue":"6","key":"390_CR12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/infdis\/161.6.1128","volume":"161","author":"T Kitamura","year":"1990","unstructured":"Kitamura T, Aso Y, Kuniyoshi N, Hara K, Yogo Y (1990) High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 161(6):1128\u20131133","journal-title":"J Infect Dis"},{"issue":"8","key":"390_CR13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/apm.12128","volume":"121","author":"HH Hirsch","year":"2013","unstructured":"Hirsch HH, Kardas P, Kranz D, Leboeuf C (2013) The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS 121(8):685\u2013727. doi: 10.1111\/apm.12128","journal-title":"APMIS"},{"issue":"4","key":"390_CR14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/(SICI)1096-9071(199912)59:4<474::AID-JMV9>3.0.CO;2-W","volume":"59","author":"WA Knowles","year":"1999","unstructured":"Knowles WA, Pillay D, Johnson MA, Hand JF, Brown DW (1999) Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 59(4):474\u2013479","journal-title":"J Med Virol"},{"issue":"1","key":"390_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/167.1.13","volume":"167","author":"RB Markowitz","year":"1993","unstructured":"Markowitz RB, Thompson HC, Mueller JF, Cohen JA, Dynan WS (1993) Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 167(1):13\u201320","journal-title":"J Infect Dis"},{"issue":"4","key":"390_CR16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/1096-9071(200012)62:4<505::AID-JMV16>3.0.CO;2-0","volume":"62","author":"M Wang","year":"2000","unstructured":"Wang M, Tsai RT, Ou WC, Lin CK, Tsay GJ, Chang H, Chang D (2000) Treatment with cytotoxic immunosuppression agents increases urinary excretion of JCV in patients with autoimmune disease. J Med Virol 62(4):505\u2013510. doi: 10.1002\/1096-9071(200012)62:4<505:AID-JMV16>3.0.CO;2-0","journal-title":"J Med Virol"},{"key":"390_CR17","author":"A Bellizzi","year":"2011","unstructured":"Bellizzi A, Anzivino E, Ferrari F, Di Nardo G, Colosimo MT, Fioriti D, Mischitelli M, Chiarini F, Cucchiara S, Pietropaolo V (2011) Polyomavirus JC reactivation and noncoding control region sequence analysis in pediatric Crohn\u2019s disease patients treated with infliximab. J Neurovirol. doi: 10.1007\/s13365-011-0036-3","journal-title":"J Neurovirol"},{"key":"390_CR18","author":"EV Arkema","year":"2012","unstructured":"Arkema EV, van Vollenhoven RF, Askling J (2012) Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2012-201638","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"390_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/314830","volume":"180","author":"A Sundsfjord","year":"1999","unstructured":"Sundsfjord A, Osei A, Rosenqvist H, Van Ghelue M, Silsand Y, Haga HJ, Rekvig OP, Moens U (1999) BK and JC viruses in patients with systemic lupus erythematosus: prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis 180(1):1\u20139. doi: 10.1086\/314830","journal-title":"J Infect Dis"},{"issue":"3","key":"390_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","volume":"68","author":"L Gorelik","year":"2010","unstructured":"Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M (2010) Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 68(3):295\u2013303. doi: 10.1002\/ana.22128","journal-title":"Ann Neurol"},{"issue":"3","key":"390_CR21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcv.2012.03.008","volume":"54","author":"J Verheyen","year":"2012","unstructured":"Verheyen J, Kaiser R, Bozic M, Timmen-Wego M, Maier BK, Kessler HH (2012) Extraction of viral nucleic acids: comparison of five automated nucleic acid extraction platforms. J Clin Virol 54(3):255\u2013259. doi: 10.1016\/j.jcv.2012.03.008","journal-title":"J Clin Virol"},{"issue":"9","key":"390_CR22","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/1352458513475489","volume":"19","author":"C Warnke","year":"2013","unstructured":"Warnke C, Pawlita M, Dehmel T, Posevitz-Fejfar A, Hartung HP, Wiendl H, Kieseier BC, Adams O (2013) An assay to quantify species-specific anti-JC virus antibody levels in MS patients. Mult Scler 19(9):1137\u20131144. doi: 10.1177\/1352458513475489","journal-title":"Mult Scler"},{"issue":"2","key":"390_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcv.2013.02.002","volume":"57","author":"P Lee","year":"2013","unstructured":"Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M (2013) A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. J Clin Virol 57(2):141\u2013146. doi: 10.1016\/j.jcv.2013.02.002","journal-title":"J Clin Virol"},{"issue":"6","key":"390_CR24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.24153","volume":"76","author":"C Warnke","year":"2014","unstructured":"Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kumpfel T, Maurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O (2014) Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 76(6):792\u2013801. doi: 10.1002\/ana.24153","journal-title":"Ann Neurol"},{"issue":"11","key":"390_CR25","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/CVI.00489-14","volume":"21","author":"P Kardas","year":"2014","unstructured":"Kardas P, Sadeghi M, Weissbach FH, Chen T, Hedman L, Auvinen E, Hedman K, Hirsch HH (2014) Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays. Clin Vaccine Immunol 21(11):1581\u20131588. doi: 10.1128\/cvi.00489-14","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"390_CR26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00430-011-0200-7","volume":"201","author":"DV Pastrana","year":"2012","unstructured":"Pastrana DV, Wieland U, Silling S, Buck CB, Pfister H (2012) Positive correlation between Merkel cell polyomavirus viral load and capsid-specific antibody titer. Med Microbiol Immunol 201(1):17\u201323. doi: 10.1007\/s00430-011-0200-7","journal-title":"Med Microbiol Immunol"},{"issue":"18","key":"390_CR27","doi-asserted-by":"crossref","first-page":"10206","DOI":"10.1128\/JVI.78.18.10206-10210.2004","volume":"78","author":"RA Pasquier Du","year":"2004","unstructured":"Du Pasquier RA, Schmitz JE, Jean-Jacques J, Zheng Y, Gordon J, Khalili K, Letvin NL, Koralnik IJ (2004) Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals. J Virol 78(18):10206\u201310210. doi: 10.1128\/jvi.78.18.10206-10210.2004","journal-title":"J Virol"},{"issue":"11","key":"390_CR28","doi-asserted-by":"crossref","first-page":"e1003014","DOI":"10.1371\/journal.ppat.1003014","volume":"8","author":"MR Perkins","year":"2012","unstructured":"Perkins MR, Ryschkewitsch C, Liebner JC, Monaco MC, Himelfarb D, Ireland S, Roque A, Edward HL, Jensen PN, Remington G, Abraham T, Abraham J, Greenberg B, Kaufman C, LaGanke C, Monson NL, Xu X, Frohman E, Major EO, Douek DC (2012) Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy. PLoS Pathog 8(11):e1003014. doi: 10.1371\/journal.ppat.1003014","journal-title":"PLoS Pathog"},{"issue":"6","key":"390_CR29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00430-014-0348-z","volume":"203","author":"BJ Weist","year":"2014","unstructured":"Weist BJ, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N (2014) The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol 203(6):395\u2013408. doi: 10.1007\/s00430-014-0348-z","journal-title":"Med Microbiol Immunol"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-015-0390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-015-0390-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-015-0390-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:11:49Z","timestamp":1559081509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-015-0390-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1007\/s00430-015-0390-5","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,13]]}}}